biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by GlassHalfEmptyon Jun 22, 2018 5:45pm

76 Views

Post# 28216339

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Wow ,

I think you are right! I'm wrong! Sorry!
Also I now agree with you: " Or, maybe I'm missing something?!?"

For sure " we " are missing something!
Its your business. I'm sure you have more experience than I.

But from my side of the fence no broker is going to take the risk of picking up a million shares plus and then just pass it along without making monies! That's not what brokers do! lol Sorry but I'm still saying this is a cross but maybe not in the sense of the word.

Regardless (no pun intended) I see it as very positive!

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading